81 FR 53491 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 156 (August 12, 2016)

Page Range		53491-53492
FR Document		2016-19192

Federal Register, Volume 81 Issue 156 (Friday, August 12, 2016)

[Federal Register Volume 81, Number 156 (Friday, August 12, 2016)]
[Notices]
[Pages 53491-53492]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19192]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Arthritis and Musculoskeletal and Skin Diseases Advisory 
Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Arthritis and Musculoskeletal and 
Skin Diseases Advisory Council.
    Date: September 13, 2016.
    Open: 8:30 a.m. to 12:00 p.m.
    Agenda: Discussion of program policies.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, C Wing, Conference Room 6, Bethesda, MD 20892.
    Closed: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, C Wing, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Laura K. Moen, Ph.D., Director, Division of 
Extramural Research Activities, NIAMS/NIH, 6700 Democracy Boulevard, 
Suite 800, Bethesda, MD 20892, 301-451-6515, moenl@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license,

[[Page 53492]]

or passport) and to state the purpose of their visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: August 5, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-19192 Filed 8-11-16; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 156 / Friday, August 12, 2016 / Notices 53491

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Average
Number of Total
Number of Total burden per
Form name responses per burden
respondents responses response
respondent hours
(in hours)

Checklist for Adding New Service ....................................................... 700 1 700 1.0 700
Checklist for Deleting Existing Service ................................................ 700 1 700 1.0 700
Checklist for Adding a New Target Population ................................... 50 1 50 0.5 25
Expanded Services .............................................................................. 1,400 1 1,400 1.0 1,400
Federal Object Class Categories ......................................................... 1,400 1 1,400 0.25 350
Supplemental Information (NEW) ........................................................ 2,000 1 2,000 0.5 1,000
Summary Page (NEW) ........................................................................ 1,700 1 1,700 0.25 425
Program Narrative Update (NEW) ....................................................... 900 1 900 4.0 3,600
Substance Abuse Progress Report (NEW) ......................................... 300 4 1,200 1.0 1,200
Health Center Controlled Networks Progress Report (NEW) ............. 93 1 93 25 2,325
Health Center Controlled Networks Work Plan (NEW) ....................... 93 1 93 5.0 465
Zika Progress Report (NEW) ............................................................... 20 4 80 1.0 80

Total .............................................................................................. 34,606 ........................ 35,566 .................... 44,608

Jason E. Bennett, Name of Committee: National Institute of The meeting will be closed to the
Director, Division of the Executive Secretariat. Biomedical Imaging and Bioengineering public in accordance with the
[FR Doc. 2016–19301 Filed 8–11–16; 8:45 am]
Special Emphasis Panel; 2017–01 R25 provisions set forth in sections
Application Review. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
BILLING CODE 4165–15–P
Date: September 28, 2016.
Time: 10:00 a.m. to 4:00 p.m.
as amended. The grant applications and
Agenda: To review and evaluate grant the discussions could disclose
DEPARTMENT OF HEALTH AND applications. confidential trade secrets or commercial
HUMAN SERVICES Place: National Institutes of Health, Two property such as patentable material,
Democracy Plaza, Suite 920, 6707 Democracy and personal information concerning
National Institutes of Health Boulevard, Bethesda, MD 20892, (Virtual individuals associated with the grant
Meeting). applications, the disclosure of which
National Institute of Biomedical Contact Person: Ruixia Zhoua, Ph.D., would constitute a clearly unwarranted
Imaging and Bioengineering; Notice of Scientific Review Officer, 6707 Democracy invasion of personal privacy.
Closed Meetings Boulevard, Democracy Two Building, Suite
957, Bethesda, MD 20892, (301) 496–473, Name of Committee: National Arthritis and
Pursuant to section 10(d) of the zhour@mail.nih.gov. Musculoskeletal and Skin Diseases Advisory
Federal Advisory Committee Act, as Council.
Dated: August 8, 2016.
amended (5 U.S.C. App.), notice is Date: September 13, 2016.
hereby given of the following meetings. David Clary, Open: 8:30 a.m. to 12:00 p.m.
The meetings will be closed to the Program Analyst, Office of Federal Advisory Agenda: Discussion of program policies.
public in accordance with the Committee Policy. Place: National Institutes of Health,
provisions set forth in sections [FR Doc. 2016–19191 Filed 8–11–16; 8:45 am] Building 31, 31 Center Drive, 6th Floor, C
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P Wing, Conference Room 6, Bethesda, MD
as amended. The grant applications and 20892.
Closed: 1:00 p.m. to 4:00 p.m.
the discussions could disclose
DEPARTMENT OF HEALTH AND Agenda: To review and evaluate grant
confidential trade secrets or commercial applications.
property such as patentable material, HUMAN SERVICES
Place: National Institutes of Health,
and personal information concerning Building 31, 31 Center Drive, 6th Floor, C
individuals associated with the grant National Institutes of Health
Wing, Conference Room 6, Bethesda, MD
applications, the disclosure of which National Institute of Arthritis and 20892.
would constitute a clearly unwarranted Musculoskeletal and Skin Diseases;
Contact Person: Laura K. Moen, Ph.D.,
invasion of personal privacy. Director, Division of Extramural Research
Notice of Meeting Activities, NIAMS/NIH, 6700 Democracy
Name of Committee: National Institute of Boulevard, Suite 800, Bethesda, MD 20892,
Biomedical Imaging and Bioengineering Pursuant to section 10(d) of the 301–451–6515, moenl@mail.nih.gov.
Special Emphasis Panel; Rapid Assessment Federal Advisory Committee Act, as Any interested person may file written
of Zika Virus Complications (2017/01). amended (5 U.S.C. App.), notice is
Date: September 12, 2016. comments with the committee by forwarding
hereby given of a meeting of the the statement to the Contact Person listed on
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
National Arthritis and Musculoskeletal this notice. The statement should include the
applications. and Skin Diseases Advisory Council. name, address, telephone number and when
Place: National Institutes of Health, Two The meeting will be open to the applicable, the business or professional
Democracy Plaza, Suite 920, 6707 Democracy public as indicated below, with affiliation of the interested person.
mstockstill on DSK3G9T082PROD with NOTICES

Boulevard, Bethesda, MD 20892, (Telephone attendance limited to space available. In the interest of security, NIH has
Conference Call). instituted stringent procedures for entrance
Individuals who plan to attend and onto the NIH campus. All visitor vehicles,
Contact Person: Dennis Hlasta, Ph.D., need special assistance, such as sign
Scientific Review Officer, National Institute including taxicabs, hotel, and airport shuttles
of Biomedical Imaging and Bioengineering, language interpretation or other will be inspected before being allowed on
National Institutes of Health, 6707 reasonable accommodations, should campus. Visitors will be asked to show one
Democracy Blvd., Bethesda, MD 20892, (301) notify the Contact Person listed below form of identification (for example, a
451–4794, dennis.hlasta@nih.gov. in advance of the meeting. government-issued photo ID, driver’s license,

VerDate Sep<11>2014 18:42 Aug 11, 2016 Jkt 238001 PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 E:\FR\FM\12AUN1.SGM 12AUN1

53492 Federal Register / Vol. 81, No. 156 / Friday, August 12, 2016 / Notices

or passport) and to state the purpose of their (Catalogue of Federal Domestic Assistance Conference Room 10, 9000 Rockville Pike,
visit. Program Nos. 93.306, Comparative Medicine; Bethesda, MD 20892.
(Catalogue of Federal Domestic Assistance 93.333, Clinical Research, 93.306, 93.333, Contact Person: Dr. Joyce Hunter,
Program Nos. 93.846, Arthritis, 93.337, 93.393–93.396, 93.837–93.844, Executive Secretary, National Institutes of
Musculoskeletal and Skin Diseases Research, 93.846–93.878, 93.892, 93.893, National Health, National Institute on Minority Health
National Institutes of Health, HHS) Institutes of Health, HHS) and Heath Disparities, 6707 Democracy
Blvd., Suite 800, Bethesda, MD 20892, (301)
Dated: August 5, 2016. Dated: August 8, 2016.
402–1366, hunterj@nih.gov.
Sylvia L. Neal, Anna Snouffer,
Any member of the public interested
Program Analyst, Office of Federal Advisory Deputy Director, Office of Federal Advisory in presenting oral comments to the
Committee Policy. Committee Policy.
committee may notify the Contact
[FR Doc. 2016–19192 Filed 8–11–16; 8:45 am] [FR Doc. 2016–19194 Filed 8–11–16; 8:45 am] Person listed on this notice at least 10
BILLING CODE 4140–01–P BILLING CODE 4140–01–P days in advance of the meeting.
Interested individuals and
representatives of organizations may
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND submit a letter of intent, a brief
HUMAN SERVICES HUMAN SERVICES description of the organization
National Institutes of Health represented, and a short description of
National Institutes of Health the oral presentation. Only one
National Institute on Minority Health representative of an organization may be
Center for Scientific Review; Notice of allowed to present oral comments and if
Closed Meetings and Health Disparities; Notice of
Meeting accepted by the committee,
presentations may be limited to five
Pursuant to section 10(d) of the Pursuant to section 10(d) of the minutes. Both printed and electronic
Federal Advisory Committee Act, as Federal Advisory Committee Act, as copies are requested for the record. In
amended (5 U.S.C. App.), notice is amended (5 U.S.C. App.), notice is addition, any interested person may file
hereby given of the following meetings. hereby given of a meeting of the written comments with the committee
The meetings will be closed to the National Advisory Council on Minority by forwarding their statement to the
public in accordance with the Health and Health Disparities. Contact Person listed on this notice. The
provisions set forth in sections The meeting will be open to the statement should include the name,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public as indicated below, with address, telephone number and when
as amended. The grant applications and attendance limited to space available. applicable, the business or professional
the discussions could disclose Individuals who plan to attend and affiliation of the interested person.
confidential trade secrets or commercial need special assistance, such as sign In the interest of security, NIH has
property such as patentable material, language interpretation or other instituted stringent procedures for
and personal information concerning reasonable accommodations, should entrance onto the NIH campus. All
individuals associated with the grant notify the Contact Person listed below visitor vehicles, including taxis, hotel,
applications, the disclosure of which in advance of the meeting. and airport shuttles, will be inspected
would constitute a clearly unwarranted The meeting will be closed to the before being allowed on campus.
invasion of personal privacy. public in accordance with the Visitors will be asked to show one form
Name of Committee: Center for Scientific
provisions set forth in sections of identification (for example, a
Review Special Emphasis Panel; Program 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., government-issued photo ID, driver’s
Projects: New Modalities for the Treatment of as amended. The grant applications and license, or passport) and to state the
Pain and Drug Abuse. the discussions could disclose purpose of their visit.
Date: September 8, 2016. confidential trade secrets or commercial
Dated: August 8, 2016.
Time: 2:30 p.m. to 5:00 p.m. property such as patentable material,
Agenda: To review and evaluate grant David Clary,
and personal information concerning
applications. individuals associated with the grant Program Analyst, Office of Federal Advisory
Place: National Institutes of Health, 6701 Committee Policy.
applications and/or contract proposals,
Rockledge Drive, Bethesda, MD 20892 [FR Doc. 2016–19190 Filed 8–11–16; 8:45 am]
(Telephone Conference Call).
the disclosure of which would
BILLING CODE 4140–01–P
Contact Person: Geoffrey G. Schofield, constitute a clearly unwarranted
Ph.D., Scientific Review Officer, Center for invasion of personal privacy.
Scientific Review, National Institutes of Name of Committee: National Advisory DEPARTMENT OF HEALTH AND
Health, 6701 Rockledge Drive, Room 4040–A, Council on Minority Health and Health
MSC 7850, Bethesda, MD 20892, 301–435–
HUMAN SERVICES
Disparities.
1235, geoffreys@csr.nih.gov. Date: September 12, 2016. National Institutes of Health
Name of Committee: Center for Scientific Closed: 3:00 p.m. to 5:00 p.m.
Review Special Emphasis Panel; PAR 16–054 Agenda: To review and evaluate grant National Human Genome Research
Shared Instrumentation: Biomedical Imaging. applications. Institute; Notice of Closed Meeting
Date: September 12, 2016. Place: National Institutes of Health, 31
Time: 8:00 a.m. to 6:00 p.m. Center Drive, Building 31, 6th Floor, Pursuant to section 10(d) of the
Agenda: To review and evaluate grant Conference Room 10, 9000 Rockville Pike, Federal Advisory Committee Act, as
applications. Bethesda, MD 20892. amended (5 U.S.C. App.), notice is
mstockstill on DSK3G9T082PROD with NOTICES

Place: Hilton Alexandria Mark Center, Date: September 13, 2016. hereby given of the following meeting.
5000 Seminary Road, Alexandria, VA 22311. Open: 8:00 a.m. to 2:30 p.m. The meeting will be closed to the
Contact Person: Jan Li, MD, Ph.D., Agenda: The agenda will include opening
Scientific Review Officer, Center for remarks, administrative matters, Director’s
public in accordance with the
Scientific Review, National Institutes of Report, NIH Health Disparities update, and provisions set forth in sections
Health, 6701 Rockledge Drive, Room 5106, other business of the Council. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Bethesda, MD 20892, 301.435.1049. jan.li@ Place: National Institutes of Health, 31 as amended. The grant applications and
nih.gov. Center Drive, Building 31, 6th Floor, the discussions could disclose

VerDate Sep<11>2014 18:42 Aug 11, 2016 Jkt 238001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 E:\FR\FM\12AUN1.SGM 12AUN1

Document Created: 2018-02-09 11:33:38
Document Modified: 2018-02-09 11:33:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 13, 2016.
FR Citation		81 FR 53491

81 FR 53491 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 156 (August 12, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health